| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Wilson Martin is a General Counsel at ROCKET PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 1,646 | $2.98 | $4,910.02 | -0.4% | +12.6% | - | |
| Aug 19, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 1,592 | $3.04 | $4,838.91 | -0.6% | +4.5% | - | |
| Aug 14, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 12,109 | $3.02 | $36,557.07 | -8.1% | +8.9% | - | |
| May 20, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 587 | $6.45 | $3,783.80 | -0.4% | -55.8% | - | |
| May 16, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 946 | $6.53 | $6,175.49 | -0.6% | -53.4% | - | |
| Feb 21, 2025 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 3,222 | $10.58 | $34,088.76 | -2.1% | -37.3% | -63.9% | |
| Nov 21, 2024 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 1,175 | $13.05 | $15,338.45 | -1.8% | -14.6% | -77.1% | |
| Aug 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 1,027 | $18.50 | $19,003.61 | -1.6% | -21.9% | -83.9% | |
| May 16, 2024 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sale+OE | 1,048 | $23.35 | $24,470.80 | -1.6% | -22.0% | -72.2% | |
| Feb 29, 2024 | RCKT Rocket Pharmaceuticals, Inc. | General Counsel | Sell | 4,100 | $29.33 | $120,257.10 | -18.0% | -29.5% | -67.7% |